BackLaboratorios Farmaceuticos Rovi, S.A. Overview
Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A. PEG Ratio

Latest PEG ratio for Laboratorios Farmaceuticos Rovi, S.A.: 6.5 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

6.50

PEG Ratio

6.50

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L) FAQ

The latest PEG ratio for 0ILL.L is 6.5. That is below the sector sector average of 10.05. Investors often review this figure alongside Laboratorios Farmaceuticos Rovi, S.A.'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, 0ILL.L currently prints 6.5 for PEG ratio, while the sector average sits near 10.05. That is roughly 35.3% below the sector mean. Large gaps often invite a closer look at Laboratorios Farmaceuticos Rovi, S.A.'s growth, margins, and balance sheet.

A PEG ratio of 6.5 for Laboratorios Farmaceuticos Rovi, S.A. is not 'good' or 'bad' on its own. Compare it with the peer average (10.05) and with 0ILL.L's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting 0ILL.L's PEG ratio (6.5), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.